Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons
Journal of Neurophysiology · 01.02.2026 · 135 (2) · 457-474
DOI: 10.1152/jn.00427.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurophysiology, erschienen am 01.02.2026. Verfasst von Viktor Yarotskyy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States. Hauptthemen laut MEDLINE: Fentanyl, Xylazine, Receptors, Dopamine D2, Corpus Striatum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute on Drug Abuse (NIDA), NIDA NIH HHS.
Abstract (Originalsprache)
Acute fentanyl and xylazine co-exposure increased the excitability of striatal dopamine receptor-(D2) expressing medium spiny neurons (MSNs) to lower intensity currents, whereas higher intensity stimuli decreased firing rates and increased the initial momentary frequency of action potentials. Fentanyl or xylazine exposure decreased D2 MSN excitability at higher current intensities with near additive decreases following co-exposure. Fentanyl and xylazine interact to selectively alter D2 MSN excitability potentially contributing to dystonia and enhancing fentanyl’s reinforcing properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
- Department of Neuroscience and Anatomy, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
- Institute for Drug and Alcohol Studies, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
ORCID-Profile: Viktor Yarotskyy, Rachel M Schmitt, Hannah J Goudsward, Sara R Nass, Kyle Harbour, A Rory McQuiston, Pamela E Knapp, Kurt F Hauser
Förderung
- HHS | NIH | National Institute on Drug Abuse (NIDA)
- NIDA NIH HHS
Zitieren
APA
Yarotskyy, V., Schmitt, R. M., Goudsward, H. J., Nass, S. R., Harbour, K., McQuiston, A. R., Knapp, P. E., & Hauser, K. F. (2026). Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons. Journal of Neurophysiology, 135(2), 457-474. https://doi.org/10.1152/jn.00427.2025
Vancouver
Yarotskyy V, Schmitt RM, Goudsward HJ, Nass SR, Harbour K, McQuiston AR, et al. Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons. Journal of Neurophysiology. 2026;135(2):457-474. doi:10.1152/jn.00427.2025
BibTeX
@article{Yarotskyy2026,
author = {Yarotskyy, Viktor and Schmitt, Rachel M and Goudsward, Hannah J and Nass, Sara R and Harbour, Kyle and McQuiston, A Rory and Knapp, Pamela E and Hauser, Kurt F},
title = {Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons},
journal = {Journal of Neurophysiology},
year = {2026},
volume = {135},
number = {2},
pages = {457--474},
doi = {10.1152/jn.00427.2025}
}
EUVIMED